JB Chemicals Q3 FY26: revenue and PAT grow; Torrent merger swap ratio 51:100
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JB Chemicals reported Q3 FY26 standalone revenue of Rs 991 crore, up 8.5% YoY, with PAT at Rs 179 crore, up 14.6%. Consolidated revenue rose 10.5% to Rs 1,065 crore and consolidated PAT grew 27.9% to Rs 208 crore YoY. For 9M FY26, consolidated revenue rose 9.3% and PAT 18.3%. CCI has approved the Torrent Pharmaceuticals merger at a swap ratio of 51 Torrent shares for every 100 JB Chemicals shares. The open offer under the acquisition is complete.
Strong consolidated PAT growth of 27.9% YoY. Torrent merger at 51:100 swap ratio awaiting further approvals; share swap terms now disclosed.